{
  "docId": "019de073-bad9-7032-8a81-e4ebe475dedb",
  "docSlug": "033dbe0b064db9b5c6a8c7c8096ccb5c",
  "documentTitle": "Genprex | Investor Presentation Deck | 44 slides",
  "authorId": "genprex",
  "authorName": "Genprex",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 44,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Uses a two-column comparison layout to highlight clinical focus areas.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bad9-7032-8a81-e4ebe475dedb/4",
  "deckHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb",
  "deckJsonHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb.json",
  "deckAnchorHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "list",
      "text": "ONCOLOGY: REQORSA is the first systemic gene therapy in development for cancer. Initially targeting solid tumors in lung cancers. Clinical trials include combinations with Tagrisso and Keytruda. Lung cancer kills 1.8 million people per year.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4bd2c549-bbb5-404e-a941-3cd0ef272c6e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.52,
        "y": 0.35
      },
      "kind": "list",
      "text": "DIABETES: Gene therapy drug candidate addresses Type 1 and Type 2 diabetes. May reduce or eliminate daily burden of checking blood glucose and need for insulin. May prevent complications. More than 537 million people with diabetes worldwide.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6fd5e6aa-6f22-4737-9793-a2e7d92779f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1. World Health Organization; 2. International Diabetes Federation; Tagrisso/Keytruda trademarks.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83e50f1c-29da-499a-9999-9adcd3963c16",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.15
      },
      "kind": "title",
      "text": "HELPING PATIENTS WITH LIMITED TREATMENT OPTIONS",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b02d7e24-8089-4525-8084-6beed0f5a326",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "ADVANCING GENE THERAPY IN LARGE INDICATIONS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b934071-72cf-49b3-9385-86e05a990ffd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "e3eb3b61-5fb8-4b44-bce2-2e6a142aa0d5",
      "evidence": "The slide title and content are focused on helping patients with limited treatment options, indicating that the audience is likely patients or medical professionals.",
      "confidence": 0.7
    },
    {
      "name": "Problem-Agitate-Solve (PAS)",
      "slug": "problem-agitate-solve-pas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "b592a607-131d-4db9-9029-178f5599fb92",
      "evidence": "The slide presents a problem (limited treatment options) and a solution (gene therapy), which is a key component of the PAS framework.",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "ecf76c1a-e52d-4444-8ea9-46984c60040c",
      "evidence": "Side-by-side comparison of two distinct therapeutic areas.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 4,
      "from": 4,
      "name": "Aha Moment",
      "slug": "03-aha-moment",
      "bestFor": "Data-heavy sections, research findings, analytical arguments",
      "matchId": "268e4ba8-a783-43fb-9599-75ead32572f5",
      "evidence": "Slide 4: HELPING PATIENTS WITH LIMITED TREATMENT OPTIONS",
      "position": 1,
      "objective": "Revealing a new approach to cancer treatment",
      "structure": "The Problem/Question -> What the Data Shows -> The Insight",
      "confidence": 0.6,
      "description": "Establish a tension, present data, then deliver the insight that changes everything"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}